EUVIMEDEUVIMED entdecken
Crossref

In vivo detection of the epimer metabolites of sweroside via ultra‐performance liquid chromatography time‐of‐flight mass spectrometry combined with DNPH derivatization

Hao Li iD, Shuhan Tang, Yaqi Xu, Yidan Sun, Pengyu Li, Xianna Li, Hailong Zhang, Masao Hattori, Zhigang Wang

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Hao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Rats, Sprague-Dawley. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The metabolites of sweroside were first investigated in vivo with ultra‐performance liquid chromatography time‐of‐flight mass spectrometry (UPLC–TOF–MS) in combination with 2,4‐dinitrophenylhydrazine derivatization. In addition, the mass detection sensitivity of the major metabolites, epinaucledal and naucledal, via UPLC–TOF–MS was significantly enhanced, and the epimer metabolites were distinctly discovered from plasma following gavage of sweroside in rats. The plasma concentration of epinaucledal and naucledal was quantified via UPLC–TOF–MS in negative mode using erythrocentaurin as the internal standard. The maximum mean plasma concentrations of naucledal and epinaucledal were 75.36 ± 20.10 and 43.52 ± 15.60 ng/ml within 2 h, respectively, following gavage of sweroside at 20 mg/kg. Moreover, the area under the concentration–time curve of naucledal was three times that of epinaucledal. The metabolic process of conversion of sweroside to epinaucledal and naucledal was deduced, and the pharmacological effects of epinaucledal and naucledal will clarify the clinical efficacy of sweroside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rats, Sprague-DawleyAnimalsChromatography, High Pressure LiquidRatsMaleIridoid GlucosidesMass SpectrometryPhenylhydrazinesReproducibility of ResultsLinear ModelsLimit of Detection

Stichwörter der Autor:innen

epinaucledalmetabolitenaucledalsweroside

Substanzen

swerosideIridoid GlucosidesPhenylhydrazines2,4-dinitrophenylhydrazine

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Institute of Natural Medicine, University of Toyama, Toyama, Japan.
  • Heilongjiang Hospital, Beijing Children's Hospital (Jiangnan Area, the Sixth Affiliated Hospital of Harbin Medical University), Harbin, China.
  • School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Shaanxi, China.

ORCID-Profile: Hao Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, H., Tang, S., Xu, Y., Sun, Y., Li, P., Li, X., Zhang, H., Hattori, M., & Wang, Z. (2024). In vivo detection of the epimer metabolites of sweroside via ultra‐performance liquid chromatography time‐of‐flight mass spectrometry combined with DNPH derivatization. Biomedical Chromatography. https://doi.org/10.1002/bmc.5966

Vancouver

Li H, Tang S, Xu Y, Sun Y, Li P, Li X, et al. In vivo detection of the epimer metabolites of sweroside via ultra‐performance liquid chromatography time‐of‐flight mass spectrometry combined with DNPH derivatization. Biomedical Chromatography. 2024. doi:10.1002/bmc.5966

BibTeX
@article{Li2024,
  author = {Li, Hao and Tang, Shuhan and Xu, Yaqi and Sun, Yidan and Li, Pengyu and Li, Xianna and Zhang, Hailong and Hattori, Masao and Wang, Zhigang},
  title = {In vivo detection of the epimer metabolites of sweroside via ultra‐performance liquid chromatography time‐of‐flight mass spectrometry combined with DNPH derivatization},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5966}
}
Kostenlos starten →